BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3841232)

  • 1. Protein C levels in disseminated intravascular coagulation and thrombotic thrombocytopenic purpura: its correlation with other coagulation parameters.
    Takahashi H; Takakuwa E; Yoshino N; Hanano M; Shibata A
    Thromb Haemost; 1985 Aug; 54(2):445-9. PubMed ID: 3841232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma level of various markers in patients with thrombotic thrombocytopenic purpura].
    Wada H; Tamaki S; Shirakawa S
    Rinsho Ketsueki; 1994 Apr; 35(4):346-51. PubMed ID: 8028179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behaviour of protein C inhibitor in intravascular coagulation and liver disease.
    Francis RB; Thomas W
    Thromb Haemost; 1984 Aug; 52(1):71-4. PubMed ID: 6548588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
    Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
    Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
    Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
    Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics Behaviors of Coagulation and Fibrinolysis Markers in Acquired Thrombotic Thrombocytopenic Purpura.
    Sakai K; Wada H; Nakatsuka Y; Kubo M; Hayakawa M; Matsumoto M
    J Intensive Care Med; 2021 Apr; 36(4):436-442. PubMed ID: 31964209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.
    Habe K; Wada H; Ito-Habe N; Hatada T; Matsumoto T; Ohishi K; Maruyama K; Imai H; Mizutani H; Nobori T
    Thromb Res; 2012 May; 129(5):598-602. PubMed ID: 22070827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in molecular markers in patients with thrombotic thrombocytopenic purpura].
    Takamatsu J
    Nihon Rinsho; 1993 Jan; 51(1):135-7. PubMed ID: 8433505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
    Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood levels of endothelin-1 and thrombomodulin in patients with disseminated intravascular coagulation and sepsis.
    Endo S; Inada K; Nakae H; Takakuwa T; Kasai T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M
    Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):277-88. PubMed ID: 8747795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation.
    Hiyoyama K; Wada H; Shimura M; Nakasaki T; Katayama N; Nishikawa M; Shiku H; Tahara T; Kato T
    Blood Coagul Fibrinolysis; 1997 Sep; 8(6):345-9. PubMed ID: 9351524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
    Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
    Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
    Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
    Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumption.
    Neame PB; Hirsh J; Browman G; Denburg J; D'Souza TJ; Gallus A; Brain MC
    Can Med Assoc J; 1976 Jun; 114(12):1108-12. PubMed ID: 1084215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma.
    Blombäck M; Eklund J; Hellgren M; Lagerkranser M; Swedenborg J
    Scand J Clin Lab Invest Suppl; 1985; 178():15-23. PubMed ID: 3867116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.